338
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Enhanced Dissolution of Ibuprofen Using Solid Dispersion with Polyethylene Glycol 20000

, , , , , , , & show all
Pages 1013-1021 | Published online: 20 Oct 2008

REFERENCES

  • C. M. Adeyeye, and J. C. Price. (1994). Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm. Res. 11:575–579.
  • C. Anastasiadou, S. Henry, B. Legendre, C. Souleau, and D. Duchene. (1983). Solid dispersions: Comparison of prepared melts and coprecipitates of diazepam and polyoxyethylene glycol 4000. Drug Dev. Ind. Pharm. 9:103–115.
  • S. T. Bowden. The phase rule and phase reactions: Theoretical and practical. Macmillan Press, London, (1938) .
  • R. Canaparo, E. Muntoni, G. P. Zara, P. C. Della, E. Berno, M. Costa, and M. Eandi. (2000). Determination of ibuprofen in human plasma by high-performance liquid chromatography: Validation and application in pharmacokinetic study. Biomed. Chromatogr. 14:219–226.
  • J. T. Carstensen. Melting point diagrams and eutecticsAdvanced pharmaceutical solids. Marcel Dekker Inc, New York, (2001) 170–189.
  • O. I. Corrigan. (1985). Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11:697–724.
  • D. Q. M. Craig. (1990). Polyethylene glycols and drug release. Drug Dev. Ind. Pharm. 16:2501–2506.
  • D. Q. M. Craig. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231:131–144.
  • J. L. Ford, and M. J. H. Rubeinstein. (1978). Phase equlibria and dissolution rates of indomethacin-polyethylene glycol 6000 solid dispersions. Pharm. Acta Helv. 53:93–98.
  • G. Geisslinger, K. Dietzel, H. Bezler, B. Nuernberg, and K. Brune. (1989). Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int. J. Clin. Pharmacol. Ther. Toxicol. 27:324–328.
  • M. K. Ghorab, and M. C. Adeyeye. (2001). Enhancement of ibuprofen, dissolution via wet granulation with beta-cyclodextrin. Pharm. Dev. Technol. 6:305–314.
  • F. Lacoulonche, A. Chauvet, J. Masse, M. A. Egea, and M. L. Garcia. (1998). An investigation of FB interactions with poly(ethylene glycol) 6000, poly(ethylene glycol) 4000 and poly-epsilon-caprolactone by thermoanalytical and spectroscopic methods and modeling. J. Pharm. Sci. 87:543–551.
  • F. Lacoulonche, A. Manderioli, G. Bramanti, and L. Ceccarelli. (1996). Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm. 22:909–916.
  • E. M. Laska, A. Sunshine, I. Marrero, N. Olson, C. Siegel, and N. McCormick. (1986). The correlation between blood levels of ibuprofen and clinical analgesic response. Clin. Pharmacol. Ther. 40:1–7.
  • D. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. Qiu, W. Wang, and W. R. Porter. (2001). Physicochemical considerations in the preparation of amorphous ritonavir/PEG 8000 solid dispersions. J. Pharm. Sci. 90:1015–1025.
  • D. Law, W. Wang, E. A. Schmitt, and A. L. Michelle. (2002). Prediction of poly (ethylene) glycol-drug eutectic compositions using an index based on the van't hoff equation. Pharm. Res. 19:315–321.
  • D. Law, W. Wang, E. A. Schmitt, Y. Qiu, L. K. Steven, and J. J. Fort. (2003). Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: The eutectic microstructure. J. Pharm. Sci. 92:505–515.
  • G. V. Moter, P. Augustijns, N. Blaton, and R. Kinget. (1998). Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 164:67–80.
  • P. Mura, A. Manderioli, G. Bramanti, and L. Ceccarelli. (1996). Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm. 22:909–916.
  • J. L. Murtha, and H. Y. Ando. (1994). Synthesis of the cholesteryl ester prodrugs cholesteryl ibuprofen and cholesteryl flufenamate and their formulation into phospholipid microemulsions. J. Pharm. Sci. 83:1222–1228.
  • N. Passerini, M. L. Gonzalez-Rodriguez, C. Cavallari, L. Rodriguez, and B. Albertini. (2002). Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur. J. Pharm. Sci. 15:71–78.
  • V. V. Podolinsky, and Y. Taran. (1981). Influence of adsorption on structure formation in eutectic systems. J. Cryst. Growth 52:82–87.
  • H. Potthast, J. B. Dressman, H. E. Junginger, K. K. Midha, H. Oeser, V. P. Shah, H. Vogelpoel, and D. M. Barends. (2005). Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen. J. Pharm. Sci. 94:2121–2131.
  • A. M. Rabasco, J. M. Ginés, M. Fernández-Arévalo, and M. A. Holgado. (1991). Dissolution rate of diazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 67:201–205.
  • A. Seo, P. Holm, H. G. Kristensen, and T. Schæfer. (2003). The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. Int. J. Pharm. 259:161–171.
  • A. T. M. Serajuddin. (1999). Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88:1058–1066.
  • R. V. Sudha, W. Zeren, H. Stefanie, and L. K. Steven. (2007). Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J. Pharm. Sci. 96:294–304.
  • M. E. Vasil'ev. (1964). Classification of the phase diagrams of binary metallic systems according to atomic interaction forces. Russ. Phys. Chem. 38:473–476.
  • S. Verheyen, N. Blaton, R. Kinget, and G. V. Mooter. (2002). Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 249:45–58.
  • T. Vilhelmsen, H. Eliasen, and T. Schæfer. (2005). Effect of a melt agglomeration process on agglomerates containing solid dispersions. Int. J. Pharm. 303:132–142.
  • N. Zerrouk, C. Chemtob, P. Arnaud, S. Toscani, and J. Dugue. (2002). In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int. J. Pharm. 225:49–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.